◎ Policy consultant and technical assistance for the application of the new drugs.
◎ The scientificity and risk evaluation for the clinical research for the post-marketing drugs.
◎ Research and technical assistance for the quality consistency evaluation for the post-marketing drugs.
◎ Scientific research for the position and re-position for the new and post-marketing drugs.
◎ Medicine investment analysis and assignment.
◎ Systematic review service for Chinese medicine.